drugset / Trial / NCT00202917
Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to study the feasibility and Toxicity of allogeneic haploidentical hematopoietic cell transplantation with CD3/CD19 depleted stem cells and a dose reduced conditioning.
Timeline
- Start
- 2004-02
- Primary completion
- 2009-07
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Fludarabine | Small molecule | — | — |
| Background | Melphalan | Small molecule | — | — |
| Background | Thiotepa | Other / unclassified | — | — |
| Background | muromonab-CD3 | Monoclonal antibody | — | — |